Hemoglobin-based blood substitutes are being developed as oxygen-carrying agents for the prevention of ischemic tissue damage and hypovolemic (low blood volume) shock.

The American Cancer Society estimates by the end of 2025, there will be around 150,000 cases of colon cancer in the U.S., and ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

The first prediction tool of its kind for early-stage classic Hodgkin lymphoma provides estimates using continuous variables capturing nonlinear context.

Luspatercept-aamt shows significant survival benefits and transfusion independence in lower-risk MDS, reshaping treatment ...

Sankalp India Foundation's proactive hemoglobinopathy prevention program averts 201 affected births, offering hope for a healthier future.

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.

Internal medicine and rheumatology specialist Siobhan Deshauer, MD, does a deep dive on the signs of kidney disease. Following is a partial transcript of the video (note that errors are possible): ...

Jurassic World Rebirth' returns dinosaurs to the spotlight with breathtaking action, rich storytelling and a fresh cast – ...

More than 30 percent of American teenagers were considered prediabetic in 2023, according to recent data from the Centers for ...

To support this advocacy, the PhilHealth Public Affairs Unit, led by Kenneth M. Po, assisted the regional information officers in the on-site registration for the Konsulta Program during the ...

During a live event, Thomas LeBlanc, MD, MA, discussed dose escalation of luspatercept in myelodysplastic syndromes and ...